By: Christina Jackson
Credit: Alfred Pasieka / Science Photo Library / Getty Images Bacteria-based cancer therapy harnesses bacteria to target cancer cells.
Christina Jackson is an Associate Editor for Genetic Engineering & Biotechnology News, BlogTalkRadio, and Inside Precision Medicine. With a focus on genetics and biotechnology, Christina covers a wide range of topics including molecular pathways, genetic mechanisms, and novel insights into diseases such as macular degeneration, cancer, and Parkinson's disease. Her articles provide valuable insights into the latest advancements in the field of genetic engineering and precision medicine.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Christina Jackson's articles mainly focus on scientific and healthcare topics, particularly cancer research and neurological disorders. She often cites data in her coverage, indicating a preference for evidence-based information.
If you want to reach out to Christina Jackson, consider providing insights or access to data related to the latest developments in cancer research, genetic mechanisms underlying diseases, therapeutic targets such as immunotherapy or protein inhibitors, and advancements in areas like CRISPR therapy and RNA epigenetics. Additionally, if your expertise lies within biopharmaceuticals or stem cell research with potential applications in healthcare and disease treatment, this could be of interest to her audience.
Given that there is no specified geographic focus for Christina's articles, she may cover global scientific and healthcare developments without regional limitations.
This information evolves through artificial intelligence and human feedback. Improve this profile .